Medical Article

The label expansion for Boehringer Ingelheim’s Hernexeos was made under an FDA pilot program that accelerates regulatory review of products with national interest. The daily pill is now approved as a first-line treatment for HER2-positive non-small lung cancer, an indication with few treatment options. The post FDA Voucher Leads to Speedy Approval of Boehringer Drug…

Collective Health partnered with Google Cloud to launch an AI-powered system that helps members navigate benefits and streamlines plan administration for employers. The post Collective Health Collaborates with Google Cloud to Launch New AI-Powered System appeared first on MedCity News.

[Sponsored] Biological samples act as a foundation of modern scientific research and medicine, providing breakthroughs in diagnostics, therapeutic development and understanding of human biology. The post Where to Buy Laboratory Freeze Dryers for Sample Preservation appeared first on MedCity News.

Boehringer Ingelheim receives rights to oral small molecules from Sitryx with potential applications in multiple autoimmune disorders. Depending on the progress of Boehringer’s research, Sitryx could receive more than $500 million. The post Boehringer Boosts Pipeline, Adding Oral Small Molecules With Broad Immunology & Inflammation Potential appeared first on MedCity News.

The core challenge for leadership is no longer merely managing direct vendors; it’s the cascading risk of the “nth-party” supplier. The post Compliance: Why Your Vendor’s Vendor is a Growth Risk appeared first on MedCity News.

It’s not just about awareness but also a call to action for patients, families, employers, payers and policymakers to modernize the systems that shape access to care. It must focus on connecting innovation with the infrastructure that governs approval, coverage and affordability. The post Rare Disease Day 2026: From Awareness to Access in a Volatile…

This disconnect has become one of the defining operational challenges facing Medicaid plans. What was once considered an under-the-radar risk is no longer subtle. It is now actively shaping plan performance, provider behavior, and financial outcomes across Medicaid systems. The post HR1 Is Stress Testing Medicaid Performance Metrics and Exposing a Failure in Engagement appeared…